dc.contributor.author | Gurdol, F | |
dc.contributor.author | Oner-Iyidogan, Y | |
dc.contributor.author | Esin, D | |
dc.contributor.author | Kocak, T | |
dc.contributor.author | Kocak, H | |
dc.date.accessioned | 2021-03-03T14:25:02Z | |
dc.date.available | 2021-03-03T14:25:02Z | |
dc.date.issued | 2005 | |
dc.identifier.citation | Kocak H., Oner-Iyidogan Y., Gurdol F., Kocak T., Esin D., "The relation between serum MDA and cystatin C levels in chronic spinal cord injury patients", CLINICAL BIOCHEMISTRY, cilt.38, sa.11, ss.1034-1037, 2005 | |
dc.identifier.issn | 0009-9120 | |
dc.identifier.other | av_3960175b-5bfe-4c5b-8f12-a73e44b9c323 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/42610 | |
dc.identifier.uri | https://doi.org/10.1016/j.clinbiochem.2005.08.005 | |
dc.description.abstract | Objectives: The assessment of renal function is particularly important in patients with spinal cord injury (SCI). Creatinine (Cr) is known to be unsuitable as a marker of renal function in SCI because of muscle wasting. Although cystatin C (cys-C) is more reliable than Cr, its expression may be affected by oxidative stress accompanying SCI. The aim of the study was to estimate the cys-C levels in SCI patients with normal functioning kidneys. The prooxidant/antioxidant state in plasma of the patients and controls was measured, and any correlations between these parameters and cys-C were determined. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.title | The relation between serum MDA and cystatin C levels in chronic spinal cord injury patients | |
dc.type | Makale | |
dc.relation.journal | CLINICAL BIOCHEMISTRY | |
dc.contributor.department | , , | |
dc.identifier.volume | 38 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 1034 | |
dc.identifier.endpage | 1037 | |
dc.contributor.firstauthorID | 22041 | |